Background The aim of this study was to provide a guidance for the management of
neuroendocrine tumors (NETs) in clinical practice. Material and Methods Nominal group and …

Simple Summary Cytotoxic chemotherapy is a standard therapy for patients with poorly
differentiated neuroendocrine carcinomas, however, its role in patients with well …

The systemic treatment of patients with pancreatic neuroendocrine tumors is based on
placebo-controlled trials and long-established chemotherapy approaches. In addition …

The landscape of treatment options in neuroendocrine tumors (NET) has changed in the last
5 years. Novel targeted drugs have been introduced and approved for distinct types of NET …

Purpose Neuroendocrine tumors (NETs) are a diverse group of malignancies that pose
challenges common to all rare tumors. The Commonwealth Neuroendocrine Tumor …

Background: Several randomized phase III trials in neuroendocrine tumors (NETs) showed
the clinical role of new targeted agents and their impact on tumor response and outcome of …

Purpose The purpose of the present review was to determine which antineoplastic systemic
therapy is most effective in improving clinical outcomes for patients with incurable …

BACKGROUND: In recent years, several treatment modalities have proved to be effective in
the treatment of neuroendocrine tumours (NETs). However, there is currently no consensus …

Neuroendocrine neoplasms (NEN) most commonly arise in the gastroenteropancreatic
system and lungs. The incidence of NEN is increasing globally, with improved diagnostic …

Importance Multiple therapies are currently available for patients with neuroendocrine
tumors (NETs), yet many therapies have not been compared head-to-head within …